Skip to Content

Print Document Text

Download PDF



SENATE DOCKET, NO. 396         FILED ON: 1/19/2011

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 992

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Steven A. Tolman

_______________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
              Court assembled:

              The undersigned legislators and/or citizens respectfully petition for the passage of the accompanying:

An Act to eliminate the abuse of controlled-release hydromorphone..

_______________

PETITION OF:

 

Name:

District/Address:

Steven A. Tolman


                                [District]
                           


SENATE DOCKET, NO. 396        FILED ON: 1/19/2011

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 992

By Mr. Tolman, petition (accompanied by bill, Senate, No. 992) of Tolman for legislation to eliminate the abuse of controlled-relase hydromorphone [Joint Committee on Mental Health and Substance Abuse].

 

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE
                                SENATE
                            , NO. 756 OF 2009-2010.]


The Commonwealth of Massachusetts
 

 

An Act to eliminate the abuse of controlled-release hydromorphone..
 

              Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

              SECTION 1. Chapter 94C of the General Laws, as appearing in the 2002 Official Edition, is hereby amended by inserting after section 3 the following section:-

                              Section 3A.  Notwithstanding sections 2 and 3, any preparation which contains hydromorphone, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers, if manufactured so as delay absorption into the blood system, unless the preparation contains 1 or more active nonnarcotic ingredients in recognized therapeutic amounts, shall be in schedule I.

              SECTION 2.  Section 31 of said chapter 94C of the General Laws, as so appearing, is hereby amended by inserting  after  line 85, the following paragraph:-

              Any preparation, which contains hydromorphone, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers, if manufactured so as delay absorption into the blood system, unless the preparation contains 1 or more active nonnarcotic ingredients in recognized therapeutic amounts.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.